Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3595692 | 1.00 | CYP1A2 (0.38) | CYP1A2POLBIDO1MEN1PABPC1 | |
| SCHEMBL2875396 | 1.00 | CYP1A2 (0.38) | CYP1A2POLBIDO1MEN1PABPC1 | |
| Fumaric Acid SCHEMBL2030913 | 0.91 | CYP1A2 (0.35) | CYP1A2POLBMEN1KMT2AKDM4E | |
| SCHEMBL2877929 | 0.88 | KDM4E (0.37) | POLBKDM4E | |
| SCHEMBL2869267 | 0.88 | KDM4E (0.37) | POLBKDM4E | |
| SCHEMBL2869264 | 0.88 | KDM4E (0.37) | POLBKDM4E | |
| SCHEMBL12641428 | 0.85 | — | — | |
| SCHEMBL12580487 | 0.85 | — | — | |
| SCHEMBL12580749 | 0.81 | PKM (0.31) | — | |
| SCHEMBL2891166 | 0.81 | CYP1A2 (0.37) | CYP1A2POLBIDO1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9738654-B2 | Method for producing nitrogen-containing heterocyclic N-oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9738654-B2 | Method for producing nitrogen-containing heterocyclic N-oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20150266887-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROCYCLIC N-OXIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150266887-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROCYCLIC N-OXIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| EP-1732929-B1 | TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS | NISSAN CHEMICAL IND LTD (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100069374-A1 | Tricyclic benzopyrane compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-7652008-B2 | 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20080004262-A1 | Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069374-A1 | Tricyclic benzopyrane compound | CBR1, CBR3, CYP2C9 | CYP1A2 365/4885POLB 3805/4885IDO1 2850/4885 |
| US-20150266887-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROCYCLIC N-OXIDE COMPOUND | NOS3, NOS2, SQOR | CYP1A2 145/4885POLB 2412/4885IDO1 803/4885 |
| US-20080004262-A1 | Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents | CBR1, CBR3, SCN8A | CYP1A2 385/4885POLB 3614/4885IDO1 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.